Oruka Therapeutics, Inc.
Income Statement
| Line Item | FY2015 | FY2014 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $7.1M | $5.6M |
| SG&A Expense | $4.4M | $4.1M |
| Operating Income | $-11.5M | $-9.7M |
| Operating Margin | — | — |
| Interest Expense | $4.0K | $3.0K |
| Pretax Income | — | — |
| Income Tax Expense | $0 | $0 |
| Net Income | $-11.4M | $-9.7M |
| Net Margin | — | — |
| EPS (Basic) | $-1.82 | $-3.31 |
| EPS (Diluted) | $-1.82 | $-3.31 |
| Shares Outstanding (Basic) | 9.1M | 20.5M |
| Shares Outstanding (Diluted) | 9.1M | 20.5M |
| Dividends Per Share | — | — |